PCGS Resumes Services After Brief COVID-19 Related Shutdown

Professional Coin Grading Service, PCGS, has announced that they have resumed operations in their Orange County, California offices. The office, by local order for all businesses, had been shuttered due to the COVID-19 pandemic. However, the county clarified its rules which allowed for the grading company to re-open and resume grading services.

Dear Valued Customer,

Orange County has clarified its emergency order and is now allowing businesses, including Collectors Universe, to resume operations.

As a result, Professional Coin Grading Service (PCGS) and Professional Sports Authenticator (PSA) will resume operations, effective immediately.

As evident by the multiple policy changes, this situation remains extremely fluid. Thank you for your patience and understanding as we navigate this ordeal. Ultimately, we are committed to both the health and safety of our employees and the delivery of our services to our loyal customers.

Brett Charville, President, PCGS

While the clarification has help the grading company for the short term, it is unclear if things will change again as COVID-19 (Coronavirus) continues to spread globally. It is possible that another closure could happen so collectors sending coins in for grading should expect greater-than-normal turn around time.

Originally, PCGS announced on March 17th that they were closing their California location due to the restrictions put on businesses in Orange County. When announced, the company encouraged collectors not to send coins in for grading until they opened back up, which was unclear as to when that would be at the time. Local government in Orange County then clarified the rules which allowed the company to re-open just a day later, yesterday March 18th.

COVID-19 has infected nearly 225,000 people globally, almost 9,500 of those here in the United States. Many state and local governments are putting significant restrictions on the population and business in efforts to slow the spread of the virus while research for a vaccine continues.